Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 501 to 525 of 2422

TitleReference numberPublishedLast updated
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Liposuction for chronic lymphoedemaIPG723
Epilepsies in children, young people and adultsNG217
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Intramedullary distraction for upper limb lengtheningIPG722
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Diabetes in children and young peopleQS125
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)TA782
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
Liposuction for chronic lipoedemaIPG721
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Joint replacement (primary): hip, knee and shoulderQS206
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Neonatal parenteral nutritionQS205
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779
Integrated health and social care for people experiencing homelessnessNG214

Results per page

  1. 10
  2. 25
  3. 50
  4. All